Related Experiment Video
Updated: Jan 20, 2026
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Tumor suppressor function of RUNX3 in breast cancer
1Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA. lfchen@life.illinois.edu
Abstract:
Emerging evidence indicates that RUNX3 is a tumor suppressor in breast cancer. RUNX3 is frequently inactivated in human breast cancer cell lines and cancer samples by hemizygous deletion of the Runx3 gene, hypermethylation of the Runx3 promoter, or cytoplasmic sequestration of RUNX3 protein. Inactivation of RUNX3 is associated with the initiation and progression of breast cancer. Female Runx3(+/-) mice spontaneously develop ductal carcinoma, and overexpression of RUNX3 inhibits the proliferation, tumorigenic potential, and invasiveness of breast cancer cells. This review is intended to summarize these findings and discuss the tumor suppressor function of RUNX3 in breast cancer.
Insights
RUNX3 acts as a tumor suppressor in breast cancer, preventing cancer initiation and progression. Its inactivation through gene deletion or promoter methylation is linked to breast cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- RUNX3 is increasingly recognized for its role in cancer biology.
- Evidence suggests RUNX3 functions as a tumor suppressor in breast cancer.
- Inactivation of RUNX3 is observed in human breast cancer samples.
Purpose of the Study:
- To review and summarize the evidence for RUNX3's tumor suppressor function in breast cancer.
- To discuss the mechanisms of RUNX3 inactivation in breast cancer.
- To highlight the implications of RUNX3's role in breast cancer development and progression.
Main Methods:
- Review of existing scientific literature on RUNX3 and breast cancer.
- Analysis of genetic and epigenetic alterations affecting RUNX3.
- Examination of experimental data from cell lines and animal models.
Main Results:
- RUNX3 is frequently inactivated in breast cancer via gene deletion, promoter hypermethylation, or protein mislocalization.
- Loss of RUNX3 function is associated with breast cancer initiation and progression.
- Experimental models show that RUNX3 suppresses proliferation, tumorigenicity, and invasiveness.
Conclusions:
- RUNX3 plays a critical tumor suppressor role in breast cancer.
- Understanding RUNX3 inactivation mechanisms is crucial for breast cancer research.
- RUNX3 represents a potential therapeutic target in breast cancer treatment.
More Related Videos
07:01Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
09:29Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
07:01Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:52Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...